Metabolic studies in carcinoid syndrome: observations on use of alpha-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency.
DAVIS
R B
RB
ALEXANDER
C S
CS
ADICOFF
A
A
D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives; D006801:Humans; D007538:Isoniazid / Q000628:therapy*; D008303:Malignant Carcinoid Syndrome / Q000378:metabolism*; D008750:Methyldopa; D012701:Serotonin / Q000378:metabolism*; D014364:Tryptophan / Q000172:deficiency*
D012701:Serotonin; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D007538:Isoniazid
DOPA/related compounds; ISONIAZID/therapy; MALIGNANT CARCINOID SYNDROME/metabolism; SEROTONIN/metabolism; TRYPTOPHAN/deficiency